Omkar Speciality Chemicals is currently trading at Rs 164.20, up by 2.70 points or 1.67 % from its previous closing of Rs. 161.50 on the BSE.
The scrip opened at Rs. 160.10 and has touched a high and low of Rs. 165.90 and Rs. 160.00 respectively. So far 88293 shares were traded on the counter.
The BSE group 'B ' stock of face value Rs. 10 has touched a 52 week high of Rs. 184.00 on 21-Jan-2015 and a 52 week low of Rs. 103.10 on 12-May-2014.
Last one week high and low of the scrip stood at Rs. 171.40 and Rs. 152.50 respectively. The current market cap of the company is Rs. 338.10 crore.
The promoters holding in the company stood at 63.04% while Institutions and Non-Institutions held 18.91% and 18.05% respectively.
Omkar Speciality Chemicals (OSCL) has commissioned its Unit No VI, located at Plot No B-15 & B-15, Lote Parshuram MIDC, Chiplun, in Maharashtra. The plant with a volumetric capacity of 300 Metric Tonnes Per Annum (MTPA) will manufacture a number of advance intermediates for pharma industry catering to essential life-saving drugs and veterinary APIs with the state of the art facility for production and quality control. Besides, with the commissioning of the above facility, the status of various operational capacities in OSCL and its subsidiaries has reached a total capacity of 4920 MTs per annum.
Omkar Speciality Chemicals is mainly engaged in the manufacture and sale of speciality chemicals viz., selenium compounds, iodine compounds, molybdenum compounds etc. and pharma intermediates viz., Potassium Iodate, Bismuth Ammonium Citrate, Bromoform etc.
| Company Name | CMP |
|---|---|
| BASF India | 3703.10 |
| Tata Chemicals | 709.05 |
| SRF | 2493.65 |
| Pidilite Inds. | 1393.25 |
| Deepak Nitrite | 1538.00 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: